TFC Financial Management’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
TFC Financial Management's TRAX Position: Q3 2026 in Review
TFC Financial Management held its First Tracks Biotherapeutics (TRAX) position steady in Q3 2026 at 1 share worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #1011.
TFC Financial Management first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- TFC Financial Management held 1 share of First Tracks Biotherapeutics worth $36 as of Q3 2026.
- TFC Financial Management left its First Tracks Biotherapeutics share count unchanged in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #1011 holding.
- TFC Financial Management first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.